Logo image of SASK.CA

ATHA ENERGY CORP (SASK.CA) Stock Fundamental Analysis

TSX-V:SASK - TSX Venture Exchange - CA0468241082 - Common Stock - Currency: CAD

0.37  -0.06 (-13.95%)

Fundamental Rating

2

Taking everything into account, SASK scores 2 out of 10 in our fundamental rating. SASK was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. The financial health of SASK is average, but there are quite some concerns on its profitability. SASK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SASK had negative earnings in the past year.
SASK had a negative operating cash flow in the past year.
SASK.CA Yearly Net Income VS EBIT VS OCF VS FCFSASK.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -5M -10M -15M -20M

1.2 Ratios

SASK's Return On Assets of -8.13% is on the low side compared to the rest of the industry. SASK is outperformed by 64.45% of its industry peers.
SASK's Return On Equity of -8.40% is in line compared to the rest of the industry. SASK outperforms 40.76% of its industry peers.
Industry RankSector Rank
ROA -8.13%
ROE -8.4%
ROIC N/A
ROA(3y)-303.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SASK.CA Yearly ROA, ROE, ROICSASK.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 200 -200 -400 -600 -800

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SASK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SASK.CA Yearly Profit, Operating, Gross MarginsSASK.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

6

2. Health

2.1 Basic Checks

The number of shares outstanding for SASK has been increased compared to 1 year ago.
SASK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
SASK.CA Yearly Shares OutstandingSASK.CA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
SASK.CA Yearly Total Debt VS Total AssetsSASK.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

SASK has an Altman-Z score of 8.58. This indicates that SASK is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SASK (8.58) is better than 92.42% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that SASK is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.00, SASK belongs to the top of the industry, outperforming 81.99% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 8.58
ROIC/WACCN/A
WACCN/A
SASK.CA Yearly LT Debt VS Equity VS FCFSASK.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 20M -20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.97 indicates that SASK has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.97, SASK belongs to the top of the industry, outperforming 86.26% of the companies in the same industry.
SASK has a Quick Ratio of 2.97. This indicates that SASK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.97, SASK belongs to the top of the industry, outperforming 87.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.97
SASK.CA Yearly Current Assets VS Current LiabilitesSASK.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M 40M

1

3. Growth

3.1 Past

The earnings per share for SASK have decreased strongly by -31.40% in the last year.
EPS 1Y (TTM)-31.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.35%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SASK will show a very strong growth in Earnings Per Share. The EPS will grow by 30.93% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y77.69%
EPS Next 2Y30.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SASK.CA Yearly EPS VS EstimatesSASK.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 -0.01 -0.02 -0.03

1

4. Valuation

4.1 Price/Earnings Ratio

SASK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SASK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SASK.CA Price Earnings VS Forward Price EarningsSASK.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SASK.CA Per share dataSASK.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

SASK's earnings are expected to grow with 30.93% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.93%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SASK!.
Industry RankSector Rank
Dividend Yield N/A

ATHA ENERGY CORP

TSX-V:SASK (4/21/2025, 7:00:00 PM)

0.37

-0.06 (-13.95%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners12.42%
Inst Owner ChangeN/A
Ins Owners2.97%
Ins Owner ChangeN/A
Market Cap102.82M
Analysts82.5
Price Target1.73 (367.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.83%
PT rev (3m)-14.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-42.5%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.49
P/tB 0.49
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.16
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS0.75
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.13%
ROE -8.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-303.11%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40571.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 2.97
Altman-Z 8.58
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%93.35%
EPS Next Y77.69%
EPS Next 2Y30.93%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-139.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year15.81%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6105.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1812.31%
OCF growth 3YN/A
OCF growth 5YN/A